id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-5021-0019,FDA,FDA-2023-D-5021,Processes and Practices Applicable to Bioresearch Monitoring Inspections; Guidance for Industry - Final Guidance,Other,Guidance,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T21:07:41Z,,1,0,09000064b90f609c
FDA-2023-D-5021-0018,FDA,FDA-2023-D-5021,Processes and Practices Applicable to Bioresearch Monitoring Inspections; Guidance for Industry; Availability,Notice,Notice of Availability,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:54:43Z,2025-23404,0,0,09000064b90f519d
FDA-2023-D-5021-0001,FDA,FDA-2023-D-5021,"Processes and Practices Applicable to Bioresearch Monitoring Inspections; Draft Guidance for Industry;
Availability",Notice,Notice of Availability,2024-06-05T04:00:00Z,2024,6,2024-06-05T04:00:00Z,,2024-06-05T14:00:31Z,2024-12319,0,0,0900006486596f25
FDA-2023-D-5021-0002,FDA,FDA-2023-D-5021,Processes and Practices Applicable to Bioresearch Monitoring Inspections; Draft Guidance for Industry,Other,Guidance,2024-06-05T04:00:00Z,2024,6,2024-06-05T04:00:00Z,2024-08-06T03:59:59Z,2025-12-19T21:07:49Z,,0,0,09000064865970a2